drug
argatroban
Marketedupdated 5mo agoby Mylan Institutional Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying argatroban
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 26, 2027
358 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Sep 26, 2027formulationUS 7589106358d
- Sep 26, 2027formulationUS 7687516358d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that